These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33601903)

  • 1. Efficacy of plasmapheresis as treatment for bilateral hyperviscosity syndrome related retinopathy in multiple myeloma.
    Merz T; Marchesoni I; Caminiti G; Romanelli F
    Eur J Ophthalmol; 2022 Jul; 32(4):NP48-NP51. PubMed ID: 33601903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia.
    Menke MN; Feke GT; McMeel JW; Treon SP
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1157-60. PubMed ID: 18326744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperviscosity-related retinopathy and serous macular detachment in Waldenström's macroglobulinemia: A mortal case in 5 years.
    Lai CC; Chang CH
    Eur J Ophthalmol; 2022 Jul; 32(4):NP109-NP114. PubMed ID: 33719618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of emergency apheresis in the management of plasma cell disorders.
    Kalayoglu-Besisik S
    Transfus Apher Sci; 2018 Feb; 57(1):35-39. PubMed ID: 29477943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central retinal vein occlusion due to hyperviscosity syndrome.
    Chiang CC; Begley S; Henderson SO
    J Emerg Med; 2000 Jan; 18(1):23-6. PubMed ID: 10645832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ophthalmologic techniques to assess the severity of hyperviscosity syndrome and the effect of plasmapheresis in patients with Waldenström's macroglobulinemia.
    Menke MN; Feke GT; McMeel JW; Treon SP
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):100-3. PubMed ID: 19362987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral simultaneous central retinal vein occlusion in hyperviscosity retinopathy treated with systemic immunosuppressive therapy only.
    Blau-Most M; Gepstein R; Rubowitz A
    Am J Ophthalmol Case Rep; 2018 Dec; 12():49-51. PubMed ID: 30182070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bilateral central retinal vein occlusion associated with blood hyperviscosity syndrome--case report].
    Helal J; Malerbi FK; Melaragno Filho R
    Arq Bras Oftalmol; 2005; 68(1):126-8. PubMed ID: 15824817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant multiple myeloma spectrum diagnosis in a central retinal vein occlusion: a case report and review.
    Borgman CJ
    Clin Exp Optom; 2016 Jul; 99(4):309-12. PubMed ID: 27079282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone implant for immunogammopathy maculopathy associated with IgA multiple myeloma.
    Georgakopoulos CD; Plotas P; Angelakis A; Kagkelaris K; Tzouvara E; Makri OE
    Ther Adv Ophthalmol; 2019; 11():2515841418820441. PubMed ID: 30671569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple myeloma presenting with bilateral exudative macular detachments.
    Brody JM; Butrus SI; Ashraf MF; Rabinowitz AI; Whitmore PV
    Acta Ophthalmol Scand; 1995 Feb; 73(1):81-2. PubMed ID: 7627765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperviscosity syndrome complicating immunoglobulin G myeloma-Cognisance of early plasmapheresis is crucial.
    Vivek S; Kundan M; Rajat B; Gaurav S; Manu D; Suman P; Singh V
    Semin Dial; 2023 Mar; 36(2):175-177. PubMed ID: 36541085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperviscosity syndrome].
    Hashimoto T
    Nihon Rinsho; 1995 Mar; 53(3):695-8. PubMed ID: 7699907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maculopathy in Patients with Monoclonal Gammopathy of Undetermined Significance.
    Smith SJ; Johnson MW; Ober MD; Comer GM; Smith BD
    Ophthalmol Retina; 2020 Mar; 4(3):300-309. PubMed ID: 31753810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune retinopathy associated with monoclonal gammopathy of undetermined significance: a case report.
    Eton EA; Abrams G; Khan NW; Fahim AT
    BMC Ophthalmol; 2020 Apr; 20(1):153. PubMed ID: 32299429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical coherence tomography angiography characteristics in Waldenström macroglobulinemia retinopathy: A case report.
    Li J; Zhang R; Gu F; Liu ZL; Sun P
    World J Clin Cases; 2020 Dec; 8(23):6071-6079. PubMed ID: 33344607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An otherwise healthy young man presents with bilateral CRVO as the first sign of hyperviscosity syndrome in the setting of new multiple myeloma.
    Golesic EA; Sheidow TG
    Retin Cases Brief Rep; 2015; 9(1):38-40. PubMed ID: 25383860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperviscosity Retinopathy and Immunogammopathy Maculopahy as New Onset of Multiple Myeloma.
    Ferreira Santos da Cruz N; Milhomens Filho JAP; Ferraro DMN; Polizelli MU; de Moraes Ambrogini NSB
    Case Rep Ophthalmol; 2021; 12(2):578-584. PubMed ID: 34326757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperviscosity syndrome in multiple myeloma.
    Kopp WL; Beirne GJ; Burns RO
    Am J Med; 1967 Jul; 43(1):141-6. PubMed ID: 4951414
    [No Abstract]   [Full Text] [Related]  

  • 20. Autoimmune retinopathy in a patient with smoldering multiple myeloma: a case report.
    Bergman Z; Mohammed T; Schocket L; Aouchiche R; Johnson MA
    Doc Ophthalmol; 2024 Jun; 148(3):167-171. PubMed ID: 38363513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.